Butolame, a 17β-aminoestrogen, acts as an anticoagulant and anxiolytic specifically designed for females with hypoestrogenic conditions. It presents a promising alternative replacement therapy for women experiencing menopausal symptoms, offering a potential strategy for managing their condition effectively.